New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2012
09:28 EDTIPG, MRVL, VVUS, OVTI, AIGPre-market top 5 gainers
The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. OVTI 12.6%, AIG 7.1%, IPG 2.5%, MRVL 1.7%, VVUS 1.5%.
News For OVTI;AIG;IPG;MRVL;VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
15:06 EDTAIGFed will begin study to evaluate impact of capital rules on insurance companies
Subscribe for More Information
September 29, 2014
08:24 EDTAIGAIG bailout challenged by former CEO Greenberg, WSJ reports
Subscribe for More Information
September 24, 2014
09:59 EDTMRVLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:40 EDTMRVLMarvell upgraded to Market Perform from Underperform at JMP Securities
Subscribe for More Information
September 19, 2014
11:19 EDTAIGAIG loss of Jay Wintrob a 'big deal,' says Wells Fargo
Subscribe for More Information
September 18, 2014
16:30 EDTAIGAIG Life & Retirement CEO Jay Wintrob leaving company
Subscribe for More Information
16:27 EDTVVUSOn The Fly: Closing Wrap
Subscribe for More Information
14:09 EDTVVUSVIVUS rallies, mean-reverting to intraday trend line
The shares have traded in an extremely wide range today on nearly 20 times daily average volume. An intraday trend line appears currently to be broken. That line is at $4.60 now, and projecting forward would be at the $4.80 area by the close. At the current price of $4.50, support is at $4.41 and then at $4.32.
12:45 EDTVVUSOn The Fly: Midday Wrap
Subscribe for More Information
09:36 EDTVVUSActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL YHOO TWTR VVUS RAD PWE WFM TSLA PIR SHLD
08:59 EDTVVUSOn The Fly: Pre-market Movers
Subscribe for More Information
06:05 EDTVVUSVIVUS, Auxilium announce FDA approval of STENDRA sNDA
VIVUS (VVUS) and Auxilium Pharmaceuticals (AUXL) announced that the FDA has approved a supplemental new drug application, or sNDA, for STENDRA. STENDRA is now the only FDA-approved erectile dysfunction, or ED, medication indicated to be taken as early as approximately 15 minutes before sexual activity. STENDRA is a prescription medication in a class of drugs known as phosphodiesterase type 5, or PDE5, inhibitors approved for the treatment of ED in men 18 years or older. STENDRA is available in multiple dosage strengths and may be taken with or without food and moderate alcohol consumption. In clinical studies, when compared to placebo, STENDRA helped more men achieve an erection in as early as approximately 15 minutes that lasted long enough to successfully complete sexual intercourse.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use